ZOLSKETIL

This brand name is authorized in Austria, Croatia, Estonia, France, Italy, Lithuania, Romania, Spain.

Active ingredients

The drug ZOLSKETIL contains one active pharmaceutical ingredient (API):

1	Doxorubicin hydrochloride in a pegylated liposomal formulation UNII 82F2G7BL4E - DOXORUBICIN HYDROCHLORIDE
	Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects.
	Read more about Doxorubicin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZOLSKETIL Concentrate for dispersion for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01DB01	Doxorubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1885147, 1885158, 1885169, 1885170
ES	Centro de información online de medicamentos de la AEMPS	1221629001
FR	Base de données publique des médicaments	64912833
IT	Agenzia del Farmaco	050034014, 050034026, 050034038, 050034040
LT	Valstybinė vaistų kontrolės tarnyba	1094948, 1094949, 1094950, 1094951
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68886001, W68886002, W68886003, W68886004